Clinical trials
Not yet recruiting Waldenstrom Macroglobulinemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Anne Louise Tølbøll Sørensen | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Centre Hospitalier de la côte Basque | 1 |
| French Innovative Leukemia Organisation | 1 |
| Massachusetts General Hospital | 1 |
| Peking Union Medical College Hospital | 1 |
| Seoul National University Hospital | 1 |
| Tina Baykaner | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 12 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Multiple Myeloma | 2 |
| Arrhythmias, Cardiac | 1 |
| Atrial Fibrillation | 1 |
| Hematologic Neoplasms | 1 |
| Hypertension | 1 |
| Lymphoma, Follicular | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.